ResMedRMDEarnings & Financial Report
NYSE · Health Care · Health Care Equipment
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| The Vanguard Group | 12.56% | 18.5M | — | 2024-02-13 |
| BlackRock, Inc. | 8.70% | 12.8M | — | 2024-01-25 |
Insider Transactions
Net 90d: −$5.97M · buys $0 / sells $5.97MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-07 | Farrell Michael J. | Chairman and CEO | Option exercise | 5.0K | $146.34 | $730.4K |
| 2026-04-07 | Farrell Michael J. | Chairman and CEO | Sell (open market) | 5.0K | $225.50 | $1.13M |
| 2026-04-01 | Brett Sandercock | Chief Financial Officer | Sell (open market) | 1.0K | $224.31 | $224.3K |
| 2026-04-01 | FARRELL PETER C | Director | Sell (open market) | 2.0K | $225.00 | $450.0K |
| 2026-03-09 | Farrell Michael J. | Chairman and CEO | Option exercise | 5.0K | $146.34 | $730.4K |
| 2026-03-09 | Farrell Michael J. | Chairman and CEO | Sell (open market) | 5.0K | $251.03 | $1.25M |
| 2026-03-04 | FARRELL PETER C | Director | Sell (open market) | 2.0K | $260.22 | $520.4K |
| 2026-03-02 | Brett Sandercock | Chief Financial Officer | Sell (open market) | 1.0K | $254.30 | $254.3K |
| 2026-02-09 | Farrell Michael J. | Chairman and CEO | Option exercise | 5.0K | $146.34 | $730.4K |
| 2026-02-09 | Farrell Michael J. | Chairman and CEO | Sell (open market) | 5.0K | $273.78 | $1.37M |
1–10 of 13
Page 1 / 2